MedTrace Logo

Effects of Acute Estrogen Therapy on Bone Formation

NCT02349113 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-02-16

No results posted yet for this study

Summary

This study is being done to study age-related bone changes in women. The investigators know that the major cause of osteoporosis is a shortage of the female hormone estrogen. This study will look closer at how this shortage of estrogen works to cause a decrease in bone formation.

Conditions

  • Bone Loss, Age-related

Interventions

DRUG

Estrogens (Climara)

Treatment with estrogens: Estradiol dermal patch 0.1mg/d transdermally

Sponsors & Collaborators

Principal Investigators

  • Sundeep Khosla, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-09-30
Completion
2012-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02349113 on ClinicalTrials.gov